Board Member
Ptc Therapeutics, Inc. (PTCT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Dr. Matthew B. Klein is recorded as CEO and Board Member at Ptc Therapeutics, Inc. (PTCT). Ptc Therapeutics, Inc. reported in an 8-K filed April 18, 2023 that Dr. Matthew B. Klein was appointed Chief Executive Officer and President, effective March 22, 2023. Dr. Matthew B. Klein has spoken on 1 earnings call across 1 company, most recently for Ptc Therapeutics, Inc. on April 28, 2026.
“The Agreement provides that Dr. Klein will be entitled to receive an annual base salary at the rate of $788,000, effective as of March 22, 2023, the date he was appointed Chief Executive Officer and President of the Company, and will have a target annual bonus opportunity of 75% of his annual base salary, in each case subject to adjustment.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2023-03-22–present
2023-03-22–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2023-03-22–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
